List. Specified medical conditions associated with increased risk of invasive meningococcal disease

Conditions
defects in, or deficiency of, complement components, including factor H, factor D or properdin deficiency people with acquired complement deficiency due to receipt of complement inhibitor therapy (including but not limited to eculizumab or ravulizumab) functional or anatomical asplenia, including sickle cell disease or other haemoglobinopathies, and congenital or acquired asplenia HIV, regardless of disease stage or CD4⁺ cell count haematopoietic stem cell transplant

Conditions

defects in, or deficiency of, complement components, including factor H, factor D or properdin deficiency
people with acquired complement deficiency due to receipt of complement inhibitor therapy (including but not limited to eculizumab or ravulizumab)
functional or anatomical asplenia, including sickle cell disease or other haemoglobinopathies, and congenital or acquired asplenia
HIV, regardless of disease stage or CD4⁺ cell count
haematopoietic stem cell transplant

Page history

Last updated

28 June 2023

Last reviewed

28 June 2023